Exemestane Recruiting Phase 2 Trials for Metastatic Breast Cancer Treatment

clinicaltrials.gov IdentifierTitleDrugs
NCT02188745ER Reactivation Therapy for Breast Cancer
NCT02917005PalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer
NCT03321981MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer
NCT03555877Anti-hormonal Therapie With or Without Ribociclib in HR-positive / HER2- Negative Metastatic Breast Cancer